Concepedia

Eliot Morrison

EM

2

Publications

66

Citations

2

H-Index

2022

Active since

Affiliations

Silence Therapeutics (United Kingdom)(Current)

Silence Therapeutics (Germany)

Eliot Morrison is an author at Silence Therapeutics (United Kingdom) specializing in medicine, vascular biology, and atherosclerosis.

Top concepts

Publications per year

2022–2022

2

Publications

2

Pre-clinical assessment of SLN360, a novel siRNA targeting LPA, developed to address elevated lipoprotein (a) in cardiovascular disease

David A. Rider, Mona Eisermann, Kathrin Löffler et al. · Atherosclerosis · 2022 · 55 citations

, , +8

Preclinical Toxicological Assessment of A Novel siRNA, SLN360, Targeting Elevated Lipoprotein (a) in Cardiovascular Disease

David A. Rider, Simon Chivers, Julia Aretz et al. · Toxicological Sciences · 2022 · 11 citations · Full text

, , +21

Rows per page

1–2 of 2